ATE315082T1 - Myeloider koloniestimulierungsfaktor und verwendungen davon - Google Patents
Myeloider koloniestimulierungsfaktor und verwendungen davonInfo
- Publication number
- ATE315082T1 ATE315082T1 AT01905087T AT01905087T ATE315082T1 AT E315082 T1 ATE315082 T1 AT E315082T1 AT 01905087 T AT01905087 T AT 01905087T AT 01905087 T AT01905087 T AT 01905087T AT E315082 T1 ATE315082 T1 AT E315082T1
- Authority
- AT
- Austria
- Prior art keywords
- stimulating factor
- colony stimulating
- myeloid colony
- csf5
- hyaluronidase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17791300P | 2000-01-25 | 2000-01-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE315082T1 true ATE315082T1 (de) | 2006-02-15 |
Family
ID=22650424
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT01905087T ATE315082T1 (de) | 2000-01-25 | 2001-01-25 | Myeloider koloniestimulierungsfaktor und verwendungen davon |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1250422B1 (de) |
JP (1) | JP2004500079A (de) |
AT (1) | ATE315082T1 (de) |
AU (1) | AU784155B2 (de) |
CA (1) | CA2398539C (de) |
DE (1) | DE60116466T2 (de) |
DK (1) | DK1250422T3 (de) |
ES (1) | ES2259024T3 (de) |
WO (1) | WO2001055357A2 (de) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2311973A1 (de) | 2003-03-05 | 2011-04-20 | Halozyme, Inc. | Lösliches Hyaluronidaseglykoprotein (sHASEGP), Verfahren zu dessen Herstellung, Verwendungen und pharmazeutische Zusammensetzungen, die dieses umfassen |
KR101454646B1 (ko) * | 2012-11-05 | 2014-10-27 | (주)한국비엠아이 | 히알루로니다아제의 안정화 제제 및 이를 포함하는 액상제제 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6123938A (en) * | 1996-10-17 | 2000-09-26 | The Regents Of The University Of California | Human urinary hyaluronidase |
-
2001
- 2001-01-25 JP JP2001554388A patent/JP2004500079A/ja active Pending
- 2001-01-25 ES ES01905087T patent/ES2259024T3/es not_active Expired - Lifetime
- 2001-01-25 CA CA2398539A patent/CA2398539C/en not_active Expired - Fee Related
- 2001-01-25 AU AU33004/01A patent/AU784155B2/en not_active Ceased
- 2001-01-25 EP EP01905087A patent/EP1250422B1/de not_active Expired - Lifetime
- 2001-01-25 AT AT01905087T patent/ATE315082T1/de not_active IP Right Cessation
- 2001-01-25 WO PCT/US2001/002575 patent/WO2001055357A2/en active IP Right Grant
- 2001-01-25 DK DK01905087T patent/DK1250422T3/da active
- 2001-01-25 DE DE60116466T patent/DE60116466T2/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1250422A2 (de) | 2002-10-23 |
EP1250422B1 (de) | 2006-01-04 |
DK1250422T3 (da) | 2006-05-29 |
ES2259024T3 (es) | 2006-09-16 |
DE60116466T2 (de) | 2006-09-28 |
AU3300401A (en) | 2001-08-07 |
AU784155B2 (en) | 2006-02-09 |
CA2398539C (en) | 2011-05-31 |
WO2001055357A2 (en) | 2001-08-02 |
CA2398539A1 (en) | 2001-08-02 |
DE60116466D1 (de) | 2006-03-30 |
WO2001055357A3 (en) | 2002-03-28 |
JP2004500079A (ja) | 2004-01-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60140794D1 (de) | Von casein abgeleitete peptide und deren anwendung für die therapie | |
EA200601575A1 (ru) | Казеиновые пептиды и их терапевтическое применение | |
WO2001090129A3 (en) | Prophylactic and therapeutic treatment of infectious, autoimmune and allergic diseases with mono and disaccharide-base compounds | |
DK0753053T3 (da) | Alfavirus-cDNA-vektorer | |
IL157504A0 (en) | Oncolytic virus therapy | |
MX9603925A (es) | Combinaciones de anticoagulantes y proteinas activas tromboliticamente, y usos de las mismas. | |
WO1996040940A3 (en) | A human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases | |
WO2020198695A8 (en) | Compositions, devices and methods for factor vii therapy | |
PL375113A1 (en) | Casein derived peptides and uses thereof in therapy | |
ATE315082T1 (de) | Myeloider koloniestimulierungsfaktor und verwendungen davon | |
HK1087328A1 (en) | Therapeutic composition for autoimmune conditions | |
BR0109928A (pt) | Uso de um herpes vìrus atenuado, e, método para estimular uma resposta imune em um indivìduo humano ou animal, ou para tratar ou prevenir uma infecção patogênica ou câncer em um indivìduo humano ou animal | |
WO2005042699A3 (en) | Modified polypeptides with therapeutic activity and methods of use | |
MXPA04007491A (es) | Tratamiento profilactico y terapeutico de infecciones y otras enfermedades con compuestos inmunoefectores. | |
DE60130775D1 (de) | Stimulierung der neutrophilfunktion zur behandlung von entzündlichen darmerkrankungen | |
AU2003253888A1 (en) | Combination therapies with l-fmau for the treatment of hepatitis b virus infection | |
WO2024040030A3 (en) | Treating protein misfolding disorders | |
TW200513258A (en) | Auxiliary agent for hepatitis C | |
ATE386542T1 (de) | Mittel zur stimulation des immunsystems | |
GR1002969B (el) | Φαρμακευτικο παρασκευασμα βασιζομενο σε αιωρημα εμβρυικων κυτταρων με δραση ανοσοποιητικης υποκαταστασης και μεθοδος θεραπειας του συνδρομου της επικτητης μολυνσης ανοσοποιητικης ανεπαρκειας (hiv) με τη χρηση αυτου του παρασκευασματος. | |
UA42977A (uk) | Спосіб визначення антагоністичної активності біфіформу |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 1250422 Country of ref document: EP |
|
EEIH | Change in the person of patent owner | ||
REN | Ceased due to non-payment of the annual fee |